≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Vestibular neuronitis

DOID EFO Endpoint Browser PheWeb

H8_VESTIBNEUR

vestibular neuronitis: Idiopathic inflammation of the vestibular nerve, characterized clinically by the acute or subacute onset of vertigo; nausea; and imbalance. The cochlear nerve is typically spared and hearing loss and tinnitus do not usually occur. Symptoms usually resolve over a period of days to weeks. (Adams et al., Principles of Neurology, 6th ed, p304)

Suggest a new description

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — H81.2
  • Hospital discharge: ICD-9 — 3861
  • Cause of death: ICD-10 — H81.2
  • Cause of death: ICD-9 — 3861

2 out of 7 registries used, show all original rules.

3442

4. Check minimum number of events

None

3442

5. Include endpoints

None

3442

6. Filter based on genotype QC (FinnGen only)

3442

Control definitions (FinnGen only)

Control exclude
H8_INNER

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
H81
Name in latin
Neuronitis vestibularis

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 24109 13022 10994
Only index persons 22996 12504 10492
Unadjusted period prevalence (%)
Whole population 0.34 0.37 0.31
Only index persons 0.43 0.46 0.40
Median age at first event (years)
Whole population 55.00 55.56 54.40
Only index persons 54.48 54.96 53.91

-FinnGen-

Key figures

All Female Male
Number of individuals 3442 1939 1503
Unadjusted period prevalence (%) 0.66 0.66 0.66
Median age at first event (years) 55.08 53.73 56.81

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
3053
Matched controls
30528
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H81.2
ICD-10 Finland
Vestibular neuronitis
15231.4
323.0
2769
17
R42
ICD-10 Finland
Dizziness and giddiness
11.1
323.0
1796
3491
3861A
ICD-9 Finland
Vertiginous syndromes and other disorders of vestibular system, Other and unspecified peripheral vertigo
+∞
317.3
299
*
H81.1
ICD-10 Finland
Benign paroxysmal vertigo
10.8
312.2
646
741
H81.3
ICD-10 Finland
Other peripheral vertigo
56.4
302.0
359
72
AA1AD
NOMESCO Finland
CT of head and brain
3.2
152.0
1059
4397
DFF59
NOMESCO Finland
Other assessment of balance
46.2
145.3
179
41
H81.0
ICD-10 Finland
Ménière disease
57.9
126.0
149
27
N07CA01
ATC
betahistine; oral
5.3
118.9
395
834
DFF00
NOMESCO Finland
Pure tone audiometry
4.0
103.3
454
1264
Z01.1
ICD-10 Finland
Examination of ears and hearing
2.9
78.2
552
2168
N17
ICPC
Vertigo/dizziness
3.2
78.1
458
1587
H81.9
ICD-10 Finland
Disorder of vestibular function, unspecified
32.9
77.3
102
32
H02AB04
ATC
methylprednisolone; systemic
2.5
63.7
583
2636
DFF40
NOMESCO Finland
Otoneurologic examination of vertigo
59.9
45.4
53
9
H02AB06
ATC
prednisolone; systemic
1.7
38.3
1416
10471
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
2.6
35.7
288
1193
DFF50
NOMESCO Finland
Electronystagmography
91.1
32.8
36
*
UDC00
NOMESCO Finland
Ear microscopy
2.6
32.6
250
1005
A03FA01
ATC
metoclopramide; systemic, rectal
1.8
29.9
631
3900
H81.4
ICD-10 Finland
Vertigo of central origin
16.4
29.3
47
29
N05AB04
ATC
prochlorperazine; systemic, rectal
4.4
27.3
102
240
A02BC02
ATC
pantoprazole; systemic
1.5
26.2
1887
15772
7804A
ICD-9 Finland
General symptoms, Dizziness and giddiness
5.9
25.4
72
125
R51.80
ICD-10 Finland
Headache
1.9
25.0
401
2245
H91.2
ICD-10 Finland
Sudden idiopathic hearing loss
4.1
24.1
96
240
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.5
23.6
1242
9612
H90.4
ICD-10 Finland
Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
3.1
22.8
130
433
DE2CG
NOMESCO Finland
Acoustic channel extensive MRI examination with high intensity magnet
5.5
20.5
61
113
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.1
19.9
230
1131
I10
ICD-10 Finland
Essential (primary) hypertension
1.4
19.4
1647
13803
R11
ICD-10 Finland
Nausea and vomiting
2.1
19.4
221
1076
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
1.9
18.8
277
1500
H55
ICD-10 Finland
Nystagmus and other irregular eye movements
16.3
18.3
29
18
G44.2
ICD-10 Finland
Tension-type headache
1.8
17.9
357
2140
M79.6
ICD-10 Finland
Pain in limb
1.4
17.4
956
7338
PA7AD
NOMESCO Finland
CT angiography of head and neck vasculature
3.3
16.9
86
266
H80.0
ICD-10 Finland
Otosclerosis involving oval window, nonobliterative
+∞
16.7
16
*
H81.8
ICD-10 Finland
Other disorders of vestibular function
40.3
16.3
20
5
R07.4
ICD-10 Finland
Chest pain, unspecified
1.5
16.0
731
5390
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
1.6
14.9
422
2784
N02BE01
ATC
paracetamol; systemic, rectal
1.4
14.3
2467
22748
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.5
14.2
527
3706
M03BX02
ATC
tizanidine; oral
1.3
14.1
1684
14589
PA7BD
NOMESCO Finland
CT angiography of neck and brain
3.7
13.9
60
164
DE2BG
NOMESCO Finland
Acoustic channel MRI examination with high intensity magnet
4.7
13.8
46
99
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.6
13.4
400
2668
SPAT1310
SPAT
Counselling related to known health issue
1.4
13.0
840
6565
R05
ICPC
Cough
1.5
12.9
560
4069
SPAT1153
SPAT
Removal of sutures
1.4
12.7
858
6751
PA6BD
NOMESCO Finland
Extensive CT of neck arteries
2.2
12.7
124
567
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
3.1
12.7
67
216
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.4
12.7
898
7126
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
2.5
12.5
98
402
J01FA10
ATC
azithromycin; systemic
1.3
12.5
1498
12880
G43.9
ICD-10 Finland
Migraine, unspecified
2.2
12.3
127
597
C08CA01
ATC
amlodipine; oral
1.4
12.2
960
7732
J01DB01
ATC
cefalexin; oral
1.4
12.1
2291
21019
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.4
12.0
616
4610
H82
ICPC
Vertiginous syndrome
3.5
11.9
54
156
SPAT1263
SPAT
Sampling
1.3
11.7
1116
9251
L03
ICPC
Low back symptom/complaint
1.4
11.7
597
4463
H80.9
ICD-10 Finland
Otosclerosis, unspecified
30.1
11.6
15
5
C09CA01
ATC
losartan; oral
1.4
11.6
628
4746
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
1.8
11.5
209
1212
C08CA13
ATC
lercanidipine; oral
1.5
11.3
349
2349
M70.6
ICD-10 Finland
Trochanteric bursitis
1.6
11.3
301
1954
C10AA05
ATC
atorvastatin; oral
1.3
11.1
1013
8320
R53
ICD-10 Finland
Malaise and fatigue
1.4
11.1
497
3618
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.4
10.9
544
4044
SPAT1043
SPAT
Audiometry
1.6
10.7
266
1691
Z01.8
ICD-10 Finland
Other specified special examinations
1.4
10.5
545
4076
SPAT1097
SPAT
Recording of ECG
1.5
10.4
383
2674
M01AH05
ATC
etoricoxib; oral
1.3
10.4
1573
13812
R06.0
ICD-10 Finland
Dyspnoea
1.4
10.4
618
4735
R01AD09
ATC
mometasone; nasal
1.3
10.3
1140
9597
SAA01
NOMESCO Finland
Simple examination of mouth
1.3
10.1
1864
16765
J01AA02
ATC
doxycycline; systemic
1.3
10.1
2187
20104
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.3
10.1
748
5941
UJF32
NOMESCO Finland
Coloscopy
1.4
10.0
669
5221
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.3
9.9
1211
10322
M01AE01
ATC
ibuprofen; systemic, rectal
1.4
9.8
2550
24023
A98
ICPC
Health maint/preventive medicine
1.5
9.6
2832
27238
J01FA09
ATC
clarithromycin; systemic
1.3
9.6
807
6521
A02BC05
ATC
esomeprazole; systemic
1.3
9.6
1070
8994
L08
ICPC
Shoulder symptom/complaint
1.4
9.6
470
3478
R23.8
ICD-10 Finland
Other and unspecified skin changes
1.5
9.4
376
2671
G45.0
ICD-10 Finland
Vertebro-basilar artery syndrome
2.5
9.4
72
295
M54.5
ICD-10 Finland
Low back pain
1.3
9.3
805
6523
A02BC01
ATC
omeprazole; systemic
1.3
9.2
703
5597
M01AE03
ATC
ketoprofen; systemic, rectal
1.3
9.2
977
8154
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.3
9.1
733
5880
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
1.4
9.1
392
2831
TAB00
NOMESCO Finland
Lumbar puncture
2.0
9.0
114
585
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.3
9.0
1100
9336
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.4
8.9
374
2684
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.4
8.8
542
4172
M25.5
ICD-10 Finland
Pain in joint
1.3
8.7
697
5582
P01AB01
ATC
metronidazole; oral, rectal
1.3
8.7
998
8399
S82
ICPC
Naevus/mole
1.5
8.6
289
1979
M79.1
ICD-10 Finland
Myalgia
1.5
8.6
303
2101
R75
ICPC
Sinusitis acute/chronic
2.0
8.5
106
541
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.4
8.5
387
2823
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
1.8
8.5
143
817
H93.1
ICD-10 Finland
Tinnitus
1.7
8.4
157
923
SPAT1312
SPAT
General health counselling
1.3
8.4
787
6434
A05
ICPC
Feeling ill
1.9
8.4
116
618
H21.2
ICD-10 Finland
Degeneration of iris and ciliary body
+∞
8.3
8
*
A02BC03
ATC
lansoprazole; oral
1.3
8.3
732
5938
JN3AD
NOMESCO Finland
Abdominal CT examination
1.6
8.3
189
1181
PA6BG
NOMESCO Finland
MRI examination of neck vasculature with high intensity magnet
4.8
8.2
26
55
R74
ICPC
Upper respiratory infection acute
1.3
8.2
614
4862
M54.4
ICD-10 Finland
Lumbago with sciatica
1.4
8.1
391
2878
DFF15
NOMESCO Finland
Speech audiometry
2.0
8.1
105
547
J01MA02
ATC
ciprofloxacin; systemic
1.3
8.0
996
8440
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.3
8.0
1131
9733
R03AC02
ATC
salbutamol; inhalant
1.2
8.0
1341
11773
PA6AD
NOMESCO Finland
CT of neck arteries
3.3
8.0
38
116
C09CA06
ATC
candesartan; oral
1.3
8.0
540
4208
Z01.2
ICD-10 Finland
Dental examination
1.3
7.9
992
8413
C07AB07
ATC
bisoprolol; oral
1.2
7.9
1215
10562
PA6AG
NOMESCO Finland
Limited MRI examination of neck vasculature with high intensity magnet
4.9
7.9
24
49
H83.0
ICD-10 Finland
Labyrinthitis
45.1
7.7
9
*
Z00.0
ICD-10 Finland
General medical examination
1.4
7.7
437
3313
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.2
7.7
1208
10517
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
1.6
7.7
181
1140
A04AA01
ATC
ondansetron; systemic, rectal
1.7
7.6
163
1000
N02AX02
ATC
tramadol; systemic, rectal
1.2
7.6
1102
9501
M01AX17
ATC
nimesulide; oral
1.3
7.6
621
4979
M01AB05
ATC
diclofenac; systemic, rectal
1.2
7.5
1794
16345
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.4
7.5
426
3229
H53.1
ICD-10 Finland
Subjective visual disturbances
1.7
7.4
144
857
H43.8
ICD-10 Finland
Other disorders of vitreous body
1.6
7.4
211
1393
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
1.8
7.4
128
738
A11
ICPC
Chest pain NOS
1.6
7.4
172
1080
PA7CD
NOMESCO Finland
CT angiography of neck and brain, extensive
3.1
7.4
38
124
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.2
7.4
1463
13047
L01
ICPC
Neck symptom/complaint
1.4
7.4
310
2226
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.3
7.3
540
4260
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.3
7.3
988
8438
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.3
7.3
491
3823
N03AX12
ATC
gabapentin; oral
1.4
7.2
376
2806
PA2BD
NOMESCO Finland
Extensive CT angiography of brain
2.5
7.2
52
209
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.2
7.2
1022
8775
J02AC01
ATC
fluconazole; systemic
1.3
7.2
955
8138
XF400
NOMESCO Finland
ECG with 12 standard connections
1.4
7.1
399
3018
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
1.5
7.1
272
1918
AA5BD
NOMESCO Finland
CT of cerebral ischaemia
2.4
7.1
54
224
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
1.3
7.0
489
3822
Z3229
NOMESCO Finland
Other healthcare associate professional
1.5
6.9
202
1342
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
2.1
6.8
70
333
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.3
6.7
557
4471
R01BA52
ATC
pseudoephedrine, combinations; oral
1.3
6.6
769
6442
R03DC03
ATC
montelukast; oral
1.4
6.6
368
2777
N01
ICPC
Headache
1.5
6.6
191
1268
M17.1
ICD-10 Finland
Other primary gonarthrosis
1.3
6.6
509
4041
SAA02
NOMESCO Finland
Basic examination of mouth
1.2
6.5
1617
14677
DDA00
NOMESCO Finland
Stapedotomy
70.0
6.4
7
*
M53.0
ICD-10 Finland
Cervicocranial syndrome
1.6
6.4
179
1179
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
1.8
6.4
103
584
G04CA01
ATC
alfuzosin; oral
1.4
6.4
271
1950
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
1.8
6.4
95
524
L15
ICPC
Knee symptom/complaint
1.3
6.3
498
3963
R20.2
ICD-10 Finland
Paraesthesia of skin
1.6
6.3
143
892
3868X
ICD-9 Finland
Vertiginous syndromes and other disorders of vestibular system, Other disorders of labyrinth
+∞
6.2
6
*
H80.8
ICD-10 Finland
Other otosclerosis
+∞
6.2
6
*
M01AX05
ATC
glucosamine; oral
1.3
6.2
497
3965
M01AE02
ATC
naproxen; oral, rectal
1.2
6.2
1429
12854
N02AJ06
ATC
codeine and paracetamol; systemic
1.2
6.2
936
8064
R01AD12
ATC
fluticasone furoate; nasal
1.3
6.1
680
5657
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.4
6.1
338
2549
G04BD12
ATC
mirabegron; oral
1.4
6.1
236
1668
D82
ICPC
Teeth/gum disease
1.2
6.1
806
6840
S18
ICPC
Laceration/cut
1.2
6.1
1041
9083
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.3
6.1
552
4478
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
1.3
6.0
462
3662

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
1316
8763
1.81
57.93
2.1
2.2
u/l
152.6
221.2
2.61
1254
8215
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
1539
10990
1.72
51.30
3.7
3.6
ng/l
34.8
100.1
0.91
1079
7641
(3013826) Glucose [Moles/volume] in Serum or Plasma
2142
17028
1.68
45.40
4.3
4.8
mmol/l
6.7
6.7
0.42
2028
15947
(3032080) INR in Blood by Coagulation assay
1543
11860
1.55
33.05
8.6
9.3
inr
1.2
1.3
1.64
462
3404
(3023103) Potassium [Moles/volume] in Serum or Plasma
3226
29796
2.32
32.27
18.2
16.9
mmol/l
4.0
4.0
4.19
3160
29023
(3019550) Sodium [Moles/volume] in Serum or Plasma
3217
29703
2.27
31.79
18.1
16.7
mmol/l
139.8
139.7
2.14
3161
28980
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
3123
28651
1.97
29.31
15.6
14.6
mg/l
20.3
24.3
10.74
2543
22778
(3018677) aPTT in Platelet poor plasma by Coagulation assay
679
4433
1.66
28.30
1.9
2.1
s
29.2
29.9
1.92
656
4303
(40761511) CBC panel - Blood by Automated count
3198
29822
2.02
24.95
15.5
13.6
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
2443
21355
1.50
24.26
4.5
4.1
mm/h
11.2
12.5
5.10
2248
19762
(3020564) Creatinine [Moles/volume] in Serum or Plasma
3249
30583
2.11
22.91
18.5
17.0
umol/l
79.2
77.7
1.74
3249
30572
(3031040) Bacteria [#/volume] in Urine by Automated count
2190
18847
1.45
22.67
5.1
4.5
e6/l
1713.7
1836.2
0.04
49
270
(3037467) Urinalysis macro (dipstick) panel - Urine
2264
19710
1.43
21.23
4.8
4.3
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
1163
9118
1.42
19.28
2.6
2.6
u/l
58.1
57.6
0.15
1067
8431
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
1733
14547
1.39
19.11
6.3
6.9
mmol/l
1.2
1.2
0.57
1433
12277
(3007461) Platelets [#/volume] in Blood
3324
31790
2.33
18.84
23.7
21.4
e9/l
245.9
250.5
3.95
3273
30979
(3035941) MCH [Entitic mass]
3324
31801
2.32
18.63
23.5
21.3
pg
30.3
30.3
0.00
3295
31334
(3024731) MCV [Entitic volume]
3324
31802
2.32
18.61
23.6
21.3
fl
90.9
91.2
2.41
3295
31338
(3026361) Erythrocytes [#/volume] in Blood
3324
31805
2.32
18.56
23.7
21.4
e12/l
4.5
4.5
1.88
3264
30892
(3010813) Leukocytes [#/volume] in Blood
3324
31811
2.31
18.44
23.7
21.4
e9/l
6.7
6.7
0.51
3266
30892
(3000963) Hemoglobin [Mass/volume] in Blood
3324
31815
2.31
18.37
23.8
21.5
g/l
136.1
135.3
2.90
3294
31355
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
3232
30630
1.90
18.28
11.5
10.6
u/l
27.9
26.3
0.82
3108
29569
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
2852
26237
1.51
17.76
5.2
4.8
mu/l
1.9
2.0
0.89
2600
23982
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
2452
21936
1.41
17.68
4.4
4.0
pmol/l
14.9
14.8
0.88
2207
19967
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
1581
13201
1.37
17.38
5.8
6.1
mmol/l
1.2
1.2
0.43
1431
11976
(3013512) EKG study
1078
8489
1.39
16.90
4.0
3.9
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
2884
26669
1.50
16.73
6.2
5.8
mmol/mol
39.6
39.9
1.17
2654
24656
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
2496
22510
1.40
16.31
7.8
7.7
u/l
76.7
78.5
1.18
2338
21243
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
2918
27219
1.47
14.51
14.4
13.6
ml/min/173m2
79.1
79.9
1.32
2504
22522
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1765
15247
1.32
14.32
6.1
6.3
umol/l
11.1
11.5
0.70
1657
14484
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
3080
29100
1.56
13.90
5.5
5.0
mmol/l
2.7
2.8
0.32
2834
26794
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
3013
28349
1.50
13.70
4.9
4.4
mmol/l
1.4
1.5
7.23
2765
26100
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
812
6283
1.38
13.62
1.8
1.7
mg/l
1.0
1.2
2.40
592
4836
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
302
1919
1.63
13.45
2.5
2.4
au/ml
29.3
25.1
—
6
105
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
279
1746
1.65
13.20
1.3
1.3
au/ml
50.5
47.6
0.08
11
77
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
2984
28092
1.47
12.81
5.2
4.6
mmol/l
6.0
6.0
0.04
2730
25630
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
3024
28553
1.49
12.68
4.9
4.5
mmol/l
4.6
4.7
1.14
2790
26442
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
491
3557
1.44
11.86
4.9
4.6
%
32.0
32.5
0.54
351
2393
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
2913
27389
1.41
11.76
4.4
4.0
mmol/l
1.4
1.3
3.73
2664
25047
(3015736) pH of Urine
1293
10900
1.30
11.72
3.8
3.4
—
5.8
—
0
8
(3022313) Gas panel - Capillary blood
209
1264
1.70
11.27
3.0
3.8
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
937
7603
1.32
11.13
4.6
4.1
estimate
0.0
0.0
0.05
308
2550
(3021601) Nitrite [Presence] in Urine by Test strip
1609
14047
1.27
10.75
5.4
5.0
estimate
0.0
0.0
0.50
322
2663
(3009343) pH of Capillary blood
268
1770
1.56
10.13
3.0
3.7
ph
7.4
7.4
0.26
32
237
(3000850) Epithelial cells [#/volume] in Urine
766
6118
1.32
10.02
2.7
2.6
e6/l
5.7
5.7
0.02
673
5340
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
712
5630
1.33
9.98
3.9
3.6
ng/l
395.0
403.4
0.02
542
4441
(3035350) Ketones [Presence] in Urine by Test strip
1596
14019
1.26
9.78
4.1
3.7
estimate
0.0
0.0
0.00
315
2604
(3009261) Glucose [Presence] in Urine by Test strip
1616
14218
1.26
9.75
4.2
3.7
estimate
0.0
0.0
0.03
314
2561
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
268
1794
1.54
9.54
3.0
3.7
kpa
5.1
5.2
0.63
239
1673
(3044889) 12 lead EKG panel
2247
20589
1.26
9.33
4.0
3.8
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
254
1702
1.53
9.01
3.0
3.6
mmol/l
1.4
1.9
1.36
187
1278
(3037522) Nuclear Ab [Titer] in Serum
497
3780
1.37
8.92
1.3
1.3
titre
536.6
525.9
0.04
101
817
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
1256
10820
1.25
8.83
4.4
3.9
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
51
203
2.54
8.71
1.1
1.1
mg/l
222.0
294.8
2.75
45
171
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
51
208
2.47
8.30
1.2
1.1
mg/l
32.6
42.2
1.60
41
168
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
1360
11884
1.24
8.25
2.3
2.2
nmol/l
78.0
78.2
0.12
1219
10681
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
48
191
2.53
8.22
1.0
1.0
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
998
8444
1.26
8.05
3.1
3.0
ng/l
1303.3
1378.9
0.16
862
7250
(4027681)
43
165
2.63
7.94
1.2
1.2
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2058
18842
1.23
7.82
3.4
3.1
u/l
48.4
50.4
0.48
1906
17506
(40761535) Cells panel - Urine sediment
332
2416
1.41
7.74
3.5
3.5
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
170
1079
1.61
7.67
3.4
4.0
mmol/l
24.9
24.9
0.07
154
1005
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
344
2529
1.40
7.56
2.2
2.4
ug/l
4.8
7.4
3.03
303
2252
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
58
262
2.23
7.54
1.1
1.1
—
—
—
0
0
(3019225) pH of Specimen
386
2915
1.37
7.21
4.7
4.4
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
1105
9550
1.23
7.18
5.1
4.9
ug/l
2.5
2.8
0.73
990
8577
(3024561) Albumin [Mass/volume] in Serum or Plasma
1431
12706
1.22
7.11
4.7
4.9
g/l
36.2
35.4
7.72
1322
11828
(3005719) IgG [Mass/volume] in Serum or Plasma
302
2197
1.41
7.06
2.8
2.8
g/l
10.2
10.6
1.42
272
2008
(3019150) Specific gravity of Urine by Refractometry
742
6152
1.26
6.98
4.5
4.1
kg/l
1.0
1.0
1.01
97
903
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
108
627
1.75
6.87
1.1
1.2
mmol/l
3.7
3.8
0.95
103
590
(3015377) Calcium [Moles/volume] in Serum or Plasma
1145
9976
1.22
6.79
3.1
3.4
mmol/l
2.4
2.4
0.61
980
8693
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1873
17118
1.21
6.75
2.9
2.8
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
1636
14773
1.20
6.67
5.8
6.0
e9/l
2.0
1.9
0.29
1452
12981
(3013650) Neutrophils [#/volume] in Blood by Automated count
1834
16749
1.20
6.59
8.3
9.2
e9/l
4.0
4.1
1.05
1633
14636
(3006315) Basophils [#/volume] in Blood
1601
14449
1.20
6.50
5.7
5.9
e9/l
0.0
0.0
1.25
1412
12474
(3001122) Ferritin [Mass/volume] in Serum or Plasma
1348
11974
1.21
6.48
3.0
2.8
ug/l
136.3
132.5
0.13
1230
11089
(3018010) Neutrophils/100 leukocytes in Blood
1522
13683
1.20
6.42
5.7
6.0
%
56.9
57.4
0.83
1412
12806
(3026008) Bacteria identified in Urine by Culture
999
8636
1.22
6.31
3.3
3.2
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
901
7730
1.22
6.10
2.6
2.7
umol/l
1798.4
5148.9
3.72
774
6724
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
43
188
2.30
6.10
2.0
1.9
nmol/l
16.8
18.4
0.55
38
176
(42870588) Differential panel, method unspecified - Blood
1121
9837
1.21
6.02
5.4
5.9
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
1537
13885
1.19
6.00
5.9
6.2
%
28.3
27.6
1.49
1417
12942
(3018418) pH of Serum or Plasma
1000
8684
1.21
5.98
4.0
4.2
ph
7.4
7.4
0.56
209
1676
(3018095) Leukocytes [#/volume] in Urine
1158
10211
1.20
5.87
3.9
3.7
e6/l
78.4
110.3
0.60
860
7250
(3013115) Eosinophils [#/volume] in Blood
1642
14940
1.19
5.86
5.8
6.1
e9/l
0.2
0.2
0.52
1461
13094
(3006504) Eosinophils/100 leukocytes in Blood
1494
13486
1.19
5.83
5.8
6.1
%
2.9
2.9
0.04
1386
12579
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
104
627
1.68
5.83
1.2
1.3
e6/l
10.1
25.4
0.84
82
481
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
104
627
1.68
5.83
1.3
1.4
e6/l
317.8
1519.6
1.51
88
511
(3001604) Monocytes [#/volume] in Blood
1585
14389
1.19
5.78
5.7
5.9
e9/l
0.6
0.6
0.54
1400
12421
(3000494) Fungus identified in Specimen by Culture
436
3467
1.29
5.68
1.5
1.5
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
1319
11799
1.19
5.65
2.2
2.1
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
564
4633
1.26
5.65
1.3
1.2
u/ml
12.2
11.6
0.07
211
1784
(3019069) Monocytes/100 leukocytes in Blood
1499
13561
1.19
5.64
6.1
6.4
%
8.6
8.7
0.84
1391
12707
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
592
4896
1.25
5.59
1.3
1.3
iu/ml
43.1
33.5
0.85
164
1537
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
849
7297
1.22
5.58
2.3
2.2
mg/l
3.0
3.0
0.14
714
6230
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
713
6039
1.23
5.39
1.3
1.2
u/ml
2.1
1.7
0.20
199
1579
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
1504
13647
1.18
5.38
4.1
4.1
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
104
646
1.63
5.23
1.4
1.3
u/l
11.1
10.6
0.12
79
523
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
452
3649
1.27
5.22
7.1
7.0
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
16
44
3.65
5.20
1.3
1.0
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
79
457
1.75
5.18
1.2
1.1
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
32
133
2.42
5.12
7.6
13.2
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
92
558
1.67
5.09
1.2
1.3
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
528
4355
1.25
5.08
1.5
1.4
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
911
7952
1.20
5.01
4.1
4.4
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
997
8776
1.19
4.99
3.4
3.2
e6/l
46.8
73.2
1.21
788
6752
(3022096) Basophils/100 leukocytes in Blood
1444
13115
1.17
4.98
5.9
6.1
%
0.7
0.7
0.24
1339
12236
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
36
161
2.25
4.91
1.0
1.0
u/l
1.2
1.1
0.17
14
87
(3021960) Folate [Moles/volume] in Serum or Plasma
784
6767
1.21
4.85
1.5
1.5
nmol/l
20.8
20.6
0.16
663
5771
(3036481) Cortisol [Moles/volume] in Serum or Plasma
334
2625
1.30
4.76
2.3
2.2
nmol/l
356.3
371.8
0.78
298
2420
(3048689) Calprotectin [Mass/mass] in Stool
405
3273
1.27
4.64
2.2
2.3
ug/g
121.9
144.0
0.47
310
2575
(36304419) Bacteria [Presence] in Urine
891
7834
1.19
4.44
3.3
3.0
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
725
6264
1.20
4.40
1.8
1.7
pmol/l
24310780.2
33480605.8
0.20
580
5221
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
872
7666
1.18
4.34
4.6
4.2
%
21.7
21.7
0.02
455
3761
(3033658) Prothrombin time (PT) actual/Normal
851
7467
1.19
4.33
3.7
3.9
%
90.5
89.8
0.34
837
7280
(3019309) Folate [Moles/volume] in Red Blood Cells
637
5449
1.21
4.29
1.9
1.8
nmol/l
1200.1
1179.6
0.20
486
4136
(3030467) Casts [#/volume] in Urine by Automated count
912
8057
1.18
4.28
3.3
3.1
e6/l
0.4
0.4
0.38
706
6086
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
1310
11909
1.16
4.28
2.0
2.0
pmol/l
98.7
95.0
1.76
676
6153
(3004588) Protein electrophoresis panel - Serum or Plasma
265
2057
1.31
4.16
2.2
2.5
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
257
1987
1.32
4.15
1.9
1.8
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
59
340
1.75
4.00
1.4
1.4
u/l
33.7
29.3
0.48
46
285
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
26
111
2.35
3.99
1.0
1.1
u/ml
5.0
3.6
—
5
17
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
556
4728
1.21
3.97
1.9
1.8
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
570
4862
1.21
3.94
2.7
3.4
mmol/l
0.8
0.8
0.83
534
4551
(3011397) Hemoglobin [Presence] in Urine by Test strip
764
6693
1.18
3.92
4.2
3.7
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
53
298
1.79
3.91
1.1
1.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
281
2218
1.29
3.91
1.9
1.9
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
1029
9238
1.16
3.88
3.2
3.2
mmol/l
7.9
7.5
1.81
843
7782
(40768797) Stomach Pathology biopsy report
481
4049
1.22
3.81
1.2
1.2
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
166
1218
1.38
3.80
1.9
1.9
u/l
37.4
39.3
0.55
144
1076
(3020682) Albumin/Creatinine [Ratio] in Urine
1030
9263
1.16
3.78
4.0
4.0
mg/mmol
7.0
8.9
0.86
631
5872
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
14
44
3.19
3.77
1.1
1.0
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
982
8809
1.16
3.72
3.3
3.3
mg/l
387.5
328.2
0.14
597
5584
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
370
3045
1.24
3.64
1.6
1.6
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
60
358
1.69
3.63
1.4
1.5
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
60
358
1.69
3.63
1.4
1.5
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
147
1066
1.40
3.63
1.3
1.2
u/ml
2.5
1.5
—
10
93
(3005988) Vibrio sp identified in Specimen by Organism specific culture
60
359
1.68
3.60
1.4
1.5
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
32
158
2.03
3.50
1.2
1.3
nmol/l
136.6
134.9
0.09
32
158
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
60
362
1.67
3.50
1.4
1.5
—
—
—
0
0
(3026782) Osmolality of Urine
653
5702
1.18
3.46
2.8
2.8
mosm/kgh2o
554.0
545.2
0.43
563
4843
(3024522) Salmonella sp identified in Specimen by Organism specific culture
60
365
1.66
3.40
1.4
1.5
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
95
644
1.49
3.38
2.4
2.9
kpa
8.1
8.0
0.38
83
595
(40761536) Microorganisms panel - Urine sediment
302
2455
1.25
3.33
4.5
4.1
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
150
1110
1.37
3.31
2.6
2.6
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
843
7539
1.16
3.28
3.8
3.4
—
—
—
0
0
(4094501)
116
823
1.42
3.27
1.2
1.1
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
60
369
1.64
3.27
1.4
1.5
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
2680
25880
1.16
3.26
16.1
15.5
%
40.1
39.7
1.51
1811
18348
(3007853) Bacteria identified in Skin by Aerobe culture
400
3360
1.22
3.25
2.0
1.8
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
874
7843
1.15
3.24
1.6
1.6
mmol/l
1.4
1.4
0.33
715
6551
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
96
660
1.47
3.21
2.2
2.1
u/l
3006.5
4150.6
0.18
33
254
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
300
2452
1.24
3.17
3.0
3.9
mmol/l
1.2
1.2
0.16
260
2142
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
20
85
2.36
3.15
1.5
1.2
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
81
542
1.51
3.10
2.4
2.8
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
21
92
2.29
3.10
1.1
1.2
g/l
0.4
0.3
1.43
13
74
(3020630) Protein [Mass/volume] in Serum or Plasma
302
2477
1.24
3.09
2.4
2.8
g/l
67.2
66.5
1.03
270
2270
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
39
217
1.81
3.05
1.2
1.3
mmol/l
13.7
12.3
0.43
11
63
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
10
29
3.46
3.04
1.0
1.0
—
—
—
0
0
(4034850)
130
954
1.38
3.04
7.3
10.2
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
219
1734
1.28
3.03
1.9
1.9
g/l
1.3
1.5
0.63
196
1588
(3007164) IgA [Mass/volume] in Serum or Plasma
605
5307
1.17
3.02
1.5
1.5
g/l
2.3
2.5
1.15
369
3247
(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis
5
5
10.01
2.98
3.8
1.8
—
—
—
0
0
(40768443) Skin Pathology biopsy report
166
1271
1.32
2.96
1.2
1.2
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
194
1519
1.29
2.94
2.3
2.4
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
147
1108
1.34
2.92
1.9
1.8
—
—
—
0
0
(4146454)
51
314
1.63
2.81
2.9
2.6
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
131
977
1.35
2.80
1.7
1.6
titre
288.3
359.6
—
6
47
(3003458) Phosphate [Moles/volume] in Serum or Plasma
450
3879
1.18
2.78
5.2
6.1
mmol/l
1.0
1.0
0.19
409
3608
(3007930) Methemoglobin/Hemoglobin.total in Blood
155
1189
1.32
2.75
5.0
5.9
%
0.9
0.9
0.30
144
1109
(3019060) Gas panel - Arterial blood
243
1975
1.25
2.73
4.8
5.2
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
158
1217
1.31
2.72
2.1
2.0
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
178
1395
1.29
2.70
3.6
3.4
mmol/l
25.3
25.3
0.07
171
1348
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
156
1203
1.31
2.67
4.9
5.8
%
1.6
1.6
0.17
145
1121
(3022217) INR in Platelet poor plasma by Coagulation assay
440
3802
1.18
2.64
28.5
24.8
inr
1.3
1.3
0.04
61
532
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
10
32
3.13
2.64
1.0
1.0
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
485
4225
1.17
2.64
1.8
1.7
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
108
790
1.38
2.62
1.7
1.6
mu/l
312.0
301.3
0.12
99
719
(3022145) Colonoscopy Study observation
381
3255
1.19
2.61
1.3
1.3
—
—
—
0
0
(3000012) Reticulocyte production index
29
155
1.88
2.61
2.2
1.5
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
1375
12843
1.12
2.61
9.8
9.7
e9/l
0.0
0.0
0.87
1167
10493
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
363
3090
1.20
2.59
3.3
3.5
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
100
724
1.39
2.59
1.1
1.1
u/ml
7.8
4.7
—
10
84
(3023511) Choriogonadotropin [Units/volume] in Urine
51
323
1.59
2.54
1.5
1.2
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
34
193
1.77
2.54
1.3
1.2
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
214
1730
1.25
2.54
3.5
3.3
pmol/l
4.4
4.4
0.25
189
1538
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
34
195
1.75
2.46
1.3
1.2
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
115
860
1.35
2.45
1.6
1.6
iu/ml
0.5
7.1
0.46
27
173
(3047181) Lactate [Moles/volume] in Blood
122
922
1.34
2.43
5.7
7.0
mmol/l
1.4
1.3
0.73
101
801
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
41
249
1.65
2.43
2.0
1.5
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
57
376
1.52
2.40
1.2
1.3
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
183
1465
1.26
2.38
2.9
2.9
e6/l
0.1
0.3
2.66
176
1429
(3051387) C reactive protein [Mass/volume] in Capillary blood
86
617
1.40
2.37
4.7
3.4
mg/l
23.6
28.5
0.61
51
375
(3002256) Pathology report gross observation
440
3838
1.17
2.37
1.3
1.3
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
233
1919
1.23
2.35
1.2
1.2
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
612
5475
1.14
2.33
3.1
3.1
mmol/l
2.4
2.5
1.09
534
4788
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
32
184
1.75
2.31
1.4
1.2
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
1001
9237
1.12
2.30
2.4
2.4
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
54
358
1.52
2.24
1.3
1.4
pmol/l
294.3
278.1
0.11
42
283
(40760892) CBC W Ordered Manual Differential panel - Blood
700
6336
1.13
2.23
4.9
4.6
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
9
29
3.11
2.22
1.0
1.0
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
2451
23730
1.11
2.19
18.3
17.6
%
13.6
13.7
1.70
2414
23182
(3011985) Renin [Units/volume] in Plasma
56
377
1.49
2.18
1.3
1.4
mu/l
50.4
56.0
0.13
51
336
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
59
402
1.48
2.16
1.2
1.3
nmol/l
0.6
0.6
1.07
53
384
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
30
173
1.74
2.16
1.4
1.4
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
252
2112
1.21
2.16
1.5
1.7
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
31
181
1.72
2.15
1.0
1.1
nmol/l
0.1
6.1
—
5
42
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
99
741
1.35
2.14
1.8
2.0
mg/l
10.3
11.6
0.92
88
678
(3017732) Neutrophils [#/volume] in Blood
237
1977
1.21
2.14
2.5
3.2
e9/l
4.0
4.1
0.21
185
1556
(3009445) Proteinase 3 Ab [Units/volume] in Serum
154
1227
1.27
2.11
2.0
1.5
u/ml
20.0
19.5
—
6
29
(40767503) Oxygen content in Capillary blood by calculation
86
631
1.37
2.11
2.1
2.5
%
16.7
16.1
0.72
47
327
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
62
429
1.45
2.11
1.2
1.2
u/ml
5.8
4.8
0.16
22
183
(3028271) Lactate [Moles/volume] in Capillary blood
67
471
1.43
2.10
1.5
1.9
mmol/l
1.7
1.6
0.07
67
459
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
386
3368
1.16
2.09
4.5
4.4
u/l
242.3
249.0
0.43
356
3191
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
33
198
1.67
2.08
1.3
1.3
u/ml
2.4
1.0
0.50
17
95
(1761868) Lipid panel - Serum or Plasma
1078
10035
1.11
2.08
3.1
2.9
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
118
911
1.31
2.07
3.8
4.2
mmol/l
3.8
3.9
0.69
107
857
(3018405) Lactate [Moles/volume] in Arterial blood
136
1073
1.28
2.03
3.5
3.9
mmol/l
1.3
1.3
0.35
136
1058
(3020891) Body temperature
152
1216
1.26
2.03
4.9
4.7
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
30
177
1.70
2.02
1.4
1.4
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
206
1706
1.22
2.01
1.8
1.6
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
193
1588
1.23
2.01
1.3
1.2
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
112
863
1.31
2.01
1.4
1.7
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
76
552
1.39
2.00
2.3
3.0
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
224
1874
1.21
1.98
7.2
7.3
mmol/l
24.8
24.5
0.43
208
1741
(3003327) Ova and parasites identified in Stool by Light microscopy
113
875
1.30
1.96
1.6
1.7
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
21
112
1.88
1.96
1.4
1.2
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
421
3719
1.15
1.94
5.3
7.0
mmol/l
104.7
104.3
1.47
408
3637
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
95
719
1.33
1.94
1.2
1.3
u/ml
3.3
8.1
1.41
14
126
(3027801) Oxygen [Partial pressure] in Arterial blood
387
3399
1.16
1.93
5.9
7.5
kpa
12.0
12.2
0.50
368
3243
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
387
3400
1.16
1.93
5.9
7.5
kpa
5.1
5.1
0.55
368
3246
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
86
642
1.35
1.92
3.3
3.3
u/ml
134.5
738.2
0.85
71
591
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
40
258
1.56
1.92
1.5
1.4
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
49
331
1.49
1.91
1.7
1.5
nmol/l
0.3
0.3
0.29
37
251
(3016502) Oxygen saturation in Arterial blood
347
3032
1.16
1.86
6.2
7.9
%
95.4
95.6
0.16
333
2925
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
166
1357
1.23
1.86
1.1
1.0
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
74
543
1.37
1.85
2.4
2.0
pmol/l
201.8
200.9
0.03
69
511
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
60
425
1.42
1.84
1.1
1.1
—
—
—
0
0
(3039000) Anion gap in Blood
88
665
1.33
1.83
6.8
8.1
mmol/l
11.2
11.3
0.03
77
591
(3018572) Chloride [Moles/volume] in Blood
88
666
1.33
1.82
6.8
8.1
mmol/l
104.7
105.2
0.35
77
592
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
43
286
1.51
1.82
2.6
2.9
—
—
—
0
0
(3017315) Amylase [Enzymatic activity/volume] in Urine
25
145
1.73
1.81
1.6
1.3
u/l
215.6
337.5
0.75
25
133
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
8
184
0.43
1.80
3.6
1.7
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
53
369
1.44
1.79
1.7
2.2
mg/l
33.6
22.4
0.51
17
93
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
99
766
1.30
1.76
1.2
1.2
u/ml
25.1
40.7
—
7
44
(3007566) Smooth muscle Ab [Titer] in Serum
102
793
1.29
1.75
1.2
1.2
titre
182.1
100.6
0.43
14
66
(3015235) Bicarbonate [Moles/volume] in Capillary blood
98
758
1.30
1.75
2.6
3.2
mmol/l
24.7
25.0
0.33
85
661
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
767
7075
1.11
1.74
2.3
2.4
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
96
741
1.30
1.74
2.0
1.9
nmol/l
43.3
39.7
0.72
90
711
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
613
5588
1.12
1.73
3.0
3.0
ug/l
0.8
0.8
0.28
423
3733
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
8
30
2.67
1.72
1.3
1.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
164
1352
1.22
1.72
1.4
1.4
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
542
4911
1.12
1.70
3.0
2.7
e6/l
0.9
1.1
0.88
321
2810
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
28
171
1.64
1.70
1.1
1.7
u/l
6.1
7.6
0.56
20
149
(3005322) IgE [Units/volume] in Serum or Plasma
201
1693
1.20
1.69
1.3
1.3
u/ml
197.1
207.6
0.09
190
1558
(4268621)
43
291
1.48
1.69
2.2
2.3
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
54
383
1.42
1.67
1.3
1.4
—
—
—
0
0
(3036489) Thrombin time
131
1059
1.25
1.65
1.8
1.9
s
20.7
21.6
1.66
109
928
(3004119) Hemoglobin [Mass/volume] in Venous blood
209
1772
1.19
1.65
3.4
3.2
g/l
130.1
128.4
0.53
204
1725
(3024980) IgG subclass 4 [Mass/volume] in Serum
61
444
1.38
1.64
1.3
1.7
g/l
0.6
0.8
0.97
46
344
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
114
909
1.26
1.62
2.1
1.7
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
85
653
1.31
1.61
1.4
1.4
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
90
697
1.30
1.61
1.3
1.3
miu/ml
250.2
222.0
0.30
43
307
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
103
812
1.28
1.61
1.5
1.6
g/l
0.2
0.2
0.00
94
770
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
91
706
1.30
1.61
1.2
1.2
u/ml
3.3
3.1
—
8
74
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
13
63
2.07
1.59
1.3
2.9
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
41
279
1.48
1.59
1.1
1.4
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
14
70
2.00
1.59
1.0
1.1
pmol/l
288.4
272.2
—
8
51
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
24
144
1.67
1.57
1.1
1.1
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
249
2153
1.17
1.57
1.1
1.2
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
379
3382
1.14
1.54
6.0
7.5
mmol/l
1.2
1.1
0.11
304
2636
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
142
1169
1.22
1.54
2.1
1.8
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
105
836
1.26
1.53
1.5
1.6
g/l
1.2
1.2
0.38
96
794
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
10
44
2.28
1.53
1.4
1.4
ng/l
133.7
111.5
—
10
44
(3027231) Wheat IgE Ab [Units/volume] in Serum
10
44
2.28
1.53
1.0
1.1
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
319
2816
1.15
1.53
6.5
8.3
g/l
123.7
121.5
1.15
307
2708
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
18
100
1.80
1.53
2.2
2.8
umol/l
26.4
29.5
0.64
12
71
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
5
15
3.34
1.52
1.0
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
28
177
1.59
1.51
1.0
1.0
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1008
9482
1.09
1.50
3.5
3.2
u/l
37.3
36.7
0.03
955
9009
(3036670) Protein [Mass/volume] in Synovial fluid
15
79
1.90
1.49
1.1
1.2
g/l
41.2
39.1
—
6
41
(3003740) Influenza virus B Ag [Presence] in Specimen
55
401
1.38
1.49
1.1
1.1
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
46
325
1.42
1.49
6.3
5.9
mmol/l
7.2
7.4
0.23
41
275
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
28
178
1.58
1.48
1.0
1.0
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
218
1876
1.17
1.47
6.4
9.1
%
93.2
93.8
0.61
218
1870
(3002523) Influenza virus A Ag [Presence] in Specimen
55
402
1.37
1.47
1.1
1.1
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
25
155
1.62
1.46
1.6
2.0
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
25
155
1.62
1.46
1.6
2.0
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
25
155
1.62
1.46
1.6
2.0
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
25
155
1.62
1.46
1.6
2.0
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
8
169
0.47
1.46
1.0
1.1
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
197
1683
1.18
1.45
1.5
1.5
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
7
28
2.50
1.45
1.0
1.0
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
235
2038
1.16
1.44
2.6
2.2
nmol/l
12.4
12.8
0.35
202
1807
(3011412) CD3 cells [#/volume] in Blood
39
269
1.45
1.44
2.0
2.5
e9/l
1.1
1.1
0.26
26
164
(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood
6
22
2.73
1.43
1.2
1.2
ml/s/173m2
0.8
0.9
—
6
17
(3006922) Hepatitis E virus Ab [Presence] in Serum
29
188
1.55
1.42
1.0
1.1
—
—
—
0
0
(3012544) pH of Venous blood
313
2776
1.14
1.41
3.8
3.7
—
7.4
—
0
13
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
364
3260
1.13
1.41
1.8
1.7
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
466
4235
1.12
1.41
2.6
2.5
g/l
2.4
2.3
2.48
426
3925
(40768793) Breast Pathology biopsy report
49
669
0.73
1.41
1.4
1.3
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
107
864
1.25
1.41
1.4
1.4
ug/g
278.2
280.5
0.03
57
504
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
365
3271
1.13
1.40
1.8
1.7
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
73
562
1.31
1.40
1.2
1.2
u/ml
47.9
43.2
—
10
57
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
98
784
1.26
1.40
1.3
1.4
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
9
40
2.25
1.40
1.1
1.2
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
44
313
1.41
1.39
1.4
1.3
mosm/kgh2o
283.9
277.9
0.83
34
243
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
274
2412
1.15
1.39
3.0
2.6
ml/min/173m2
63.6
65.8
0.41
103
957
(3025159) Blasts/100 leukocytes in Blood
254
2225
1.15
1.38
4.4
4.3
%
0.1
0.4
0.76
61
553
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
8
163
0.49
1.35
15.9
12.5
nmol/l
541.8
837.1
—
8
156
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
254
2229
1.15
1.35
4.0
4.0
ng/l
93.4
92.2
0.07
208
1932
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
48
349
1.38
1.34
1.2
1.3
nmol/l
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
17
97
1.76
1.34
1.8
2.0
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
17
97
1.76
1.34
1.0
1.2
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
30
199
1.51
1.34
2.3
2.2
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
24
151
1.59
1.34
1.5
1.8
u/field
3.2
3.2
0.01
19
109
(3023410) Appearance of Cerebral spinal fluid
39
274
1.43
1.32
1.2
1.5
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
45
615
0.73
1.32
2.0
1.9
nmol/l
1.0
0.8
0.92
39
508
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
464
4233
1.11
1.32
1.4
1.4
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
34
233
1.46
1.31
1.1
1.0
mg/l
287.8
288.8
0.03
28
211
(3035637) Corticotropin [Mass/volume] in Plasma
48
351
1.37
1.31
1.3
1.5
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
35
497
0.70
1.29
1.3
1.2
u/l
20.5
42.9
1.86
27
428
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
21
129
1.63
1.29
1.4
1.4
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
21
129
1.63
1.29
1.4
1.4
—
—
—
0
0
(3035880) pH of Pleural fluid
9
173
0.52
1.29
1.2
1.3
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
335
3006
1.13
1.28
1.6
1.6
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
250
2201
1.15
1.28
3.2
3.0
kpa
4.4
4.6
0.94
244
2121
(43055514) Macroprolactin [Presence] in Serum or Plasma
10
48
2.09
1.27
1.2
1.3
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
40
285
1.41
1.27
1.4
1.4
%
31.2
31.7
0.02
19
173
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
348
3132
1.12
1.27
3.9
4.1
ug/l
7.3
25.2
3.01
280
2562
(3012501) Base excess in Blood by calculation
85
678
1.26
1.27
3.0
4.8
mmol/l
2.2
2.6
0.73
56
475
(3014271) Vancomycin [Susceptibility]
21
130
1.62
1.26
3.0
2.9
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
18
107
1.69
1.25
1.1
2.1
—
29525.9
—
0
17
(3001019) Free T4 and TSH panel - Serum or Plasma
113
1361
0.82
1.24
1.6
1.7
—
—
—
0
0
(3010503) CD19 cells [#/volume] in Blood
27
179
1.51
1.23
1.5
2.5
e9/l
0.1
0.2
0.64
27
174
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
34
237
1.44
1.22
2.2
2.2
u/field
2.2
1.8
0.14
18
92
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
8
37
2.16
1.21
1.8
2.2
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
8
38
2.11
1.18
1.1
1.1
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
39
281
1.39
1.18
1.3
1.4
g/l
0.4
0.4
0.08
24
202
(3028192) IgG subclass 2 [Mass/volume] in Serum
39
281
1.39
1.18
1.3
1.4
g/l
3.2
2.9
0.48
25
202
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
25
165
1.52
1.17
1.2
1.2
ratio
1.1
1.0
—
5
61
(3022948) Iron [Moles/volume] in Serum or Plasma
498
4591
1.10
1.17
2.6
2.5
umol/l
13.9
13.1
1.63
454
4264
(3027135) IgG subclass 1 [Mass/volume] in Serum
39
282
1.39
1.16
1.3
1.4
g/l
7.5
6.9
0.41
24
204
(3034092) Cytoplasmic Ig cells/100 cells in Blood
0
34
0.00
1.16
0.0
11.5
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
61
473
1.29
1.16
1.0
1.1
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
38
274
1.39
1.15
1.5
1.7
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
38
274
1.39
1.15
1.5
1.7
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
38
274
1.39
1.15
1.5
1.7
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
432
3959
1.10
1.15
2.7
2.6
%
23.5
22.9
0.39
367
3389
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
30
207
1.45
1.15
2.3
2.2
%
14.7
13.6
0.15
12
86
(3002032) Base excess in Venous blood by calculation
297
2668
1.12
1.14
3.7
3.8
mmol/l
2.1
2.0
0.18
244
2160
(3017181) Myelocytes/100 leukocytes in Blood
279
2499
1.13
1.12
4.4
4.2
%
0.7
0.9
0.50
74
720
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
7
30
2.34
1.12
1.0
1.2
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
265
2368
1.13
1.11
4.5
4.3
%
0.1
0.1
0.41
67
657
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
155
1335
1.17
1.10
3.1
2.6
%
0.6
0.7
0.56
150
1277
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
48
364
1.32
1.08
1.3
1.5
%
55.7
59.3
0.23
22
226
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
32
227
1.41
1.07
1.2
1.2
titre
44.0
128.0
—
5
50
(3014111) Lactate [Moles/volume] in Serum or Plasma
287
2585
1.12
1.06
5.2
6.9
mmol/l
1.3
1.4
0.11
282
2493
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
394
3612
1.10
1.05
1.6
1.6
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
51
392
1.31
1.05
6.0
6.8
mg/l
11.4
11.8
0.30
46
367
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
303
2744
1.11
1.03
2.5
2.4
u/l
38.9
55.7
0.45
259
2369
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
124
1056
1.18
1.02
1.7
1.6
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
19
122
1.56
1.02
1.7
2.2
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
19
122
1.56
1.02
1.7
2.2
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
53
412
1.29
1.01
2.5
2.7
—
—
—
0
0
(3003338) MCHC [Mass/volume]
2455
24078
1.07
1.01
20.5
18.7
g/l
333.2
332.3
5.85
2444
23897
(3021447) Carbon dioxide [Partial pressure] in Venous blood
296
2682
1.11
1.00
3.7
3.7
kpa
5.8
5.8
0.21
291
2595
(4062490)
38
282
1.35
1.00
1.3
1.4
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
7
35
2.00
1.00
3.1
1.8
—
—
—
0
0
(4306422)
54
422
1.28
1.00
1.2
1.2
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
276
2492
1.12
0.99
3.0
2.9
ng/l
206.7
196.4
0.14
255
2267
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
56
440
1.28
0.99
1.3
1.2
u/ml
1.6
3.5
1.38
13
148
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
19
123
1.55
0.99
1.7
2.2
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
20
297
0.67
0.99
1.5
1.5
—
—
—
0
0
(3010421) pH of Blood
97
811
1.20
0.99
2.9
4.5
ph
7.4
7.4
0.04
83
668
(3027945) Reticulocytes/100 erythrocytes in Blood
361
3308
1.10
0.99
2.6
2.6
%
1.8
1.8
0.08
318
2933
(3033923) Metanephrine [Moles/time] in 24 hour Urine
11
61
1.81
0.98
1.0
1.1
umol/24h
0.7
0.7
—
6
34
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
41
309
1.33
0.98
1.5
1.8
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
5
23
2.18
0.98
1.2
1.0
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
9
160
0.56
0.98
1.1
6.3
—
54.9
—
0
39
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
9
50
1.80
0.96
6.9
8.1
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
10
54
1.85
0.96
1.1
1.4
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
12
69
1.74
0.96
7.2
7.9
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
11
186
0.59
0.95
1.5
1.3
—
1.4
—
0
10
(21494814) CD8 cells/100 lymphocytes in Specimen
18
117
1.54
0.93
1.7
2.1
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
35
260
1.35
0.93
1.3
1.2
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
12
70
1.72
0.92
1.0
1.0
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
91
763
1.20
0.92
3.0
3.1
mg/l
1.5
1.6
0.29
81
699
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
20
134
1.50
0.91
1.1
1.1
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
77
636
1.22
0.90
2.0
2.2
g/l
130.9
128.8
0.34
60
460
(3008757) Leukocyte morphology finding [Identifier] in Blood
41
314
1.31
0.90
3.0
4.4
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
6
29
2.07
0.89
1.7
1.6
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
19
127
1.50
0.88
1.2
1.2
—
—
—
0
0
(1002224) Polysomnography panel
129
1119
1.16
0.88
1.1
1.1
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
71
584
1.22
0.88
3.6
3.3
mmol/l
7.2
7.5
0.68
71
569
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
22
152
1.45
0.88
1.1
1.1
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
11
181
0.61
0.87
1.1
1.1
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
113
971
1.17
0.87
2.6
2.7
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
6
30
2.00
0.87
1.0
1.9
—
—
—
0
0
(4010399)
225
2028
1.12
0.86
1.3
1.4
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
75
623
1.21
0.85
3.5
3.1
mmol/l
1.5
1.6
0.13
75
604
(3032352) Blasts [#/volume] in Cerebral spinal fluid
6
31
1.94
0.84
1.3
1.4
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
8
45
1.78
0.84
2.3
1.3
—
—
—
0
0
(3022621) pH of Urine by Test strip
211
1901
1.12
0.83
3.2
3.1
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
64
525
1.22
0.82
1.3
1.5
—
—
—
0
0
(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum
6
32
1.88
0.81
1.5
1.1
u/ml
3.3
3.1
—
6
22
(3045424) Erythrocytes [Presence] in Urine
62
508
1.22
0.81
1.6
1.6
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
13
81
1.61
0.81
1.1
1.1
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
125
1091
1.15
0.80
1.4
1.3
iu/l
27.9
31.1
0.51
100
929
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
19
130
1.46
0.80
1.1
1.7
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
115
998
1.16
0.80
3.2
3.2
u/ml
0.4
0.3
0.63
71
577
(3016228) CD19 cells/100 cells in Blood
18
122
1.48
0.80
1.7
2.1
%
7.1
8.5
0.36
18
117
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
45
356
1.27
0.80
1.2
1.1
u/ml
2.6
2.2
0.14
18
150
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
10
58
1.73
0.79
1.0
1.2
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
0
24
0.00
0.79
0.0
1.3
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
250
2280
1.10
0.79
4.4
4.0
%
0.6
0.6
0.03
58
507
(3019420) Tryptase [Mass/volume] in Serum or Plasma
20
139
1.44
0.79
2.2
1.6
ug/l
16.4
9.4
0.48
15
115
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
203
1831
1.12
0.79
1.3
1.2
iu/ml
102.3
151.9
1.39
84
666
(3000991) Gas panel - Venous blood
263
2405
1.10
0.79
6.4
8.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
73
611
1.20
0.78
1.2
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
73
611
1.20
0.78
1.2
1.3
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
19
131
1.45
0.78
1.2
1.3
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
12
74
1.62
0.78
1.0
1.1
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
5
96
0.52
0.78
2.6
2.2
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
18
123
1.47
0.77
1.4
1.2
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
21
292
0.72
0.77
5.8
3.8
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
57
466
1.23
0.77
1.1
1.1
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
26
349
0.74
0.77
1.2
1.6
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
26
191
1.36
0.77
1.4
1.6
u/l
9.2
6.4
0.28
11
95
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
60
725
0.82
0.76
1.6
1.6
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
74
622
1.19
0.76
1.5
1.7
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
6
34
1.77
0.76
1.0
1.2
umol/24h
1.4
1.8
—
6
34
(3042552) Rheumatoid factor [Units/volume] in Pleural fluid
0
28
0.00
0.76
0.0
1.0
—
8.1
—
0
10
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
0
28
0.00
0.76
0.0
1.3
—
22.5
—
0
28
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
33
427
0.77
0.76
1.4
1.5
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
16
107
1.50
0.76
1.1
1.0
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
102
882
1.16
0.75
1.9
2.1
%
96.0
90.1
2.38
95
828
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
116
1013
1.15
0.75
2.0
2.2
ug/l
299.6
738.9
1.19
109
953
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
23
166
1.39
0.75
1.1
1.2
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
25
336
0.74
0.75
1.4
1.4
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
39
306
1.28
0.75
1.1
1.2
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
86
735
1.17
0.74
1.1
1.2
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
37
289
1.28
0.73
3.6
3.8
%
62.0
56.9
0.59
26
185
(3027944) Amphetamines [Presence] in Urine
84
717
1.18
0.73
2.7
2.0
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
69
579
1.20
0.73
1.2
1.2
u/ml
3.0
6.5
—
7
47
(3042111) Morphology [Interpretation] in Bone marrow Narrative
42
524
0.80
0.73
1.4
1.6
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
441
4140
1.07
0.73
2.1
2.1
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
25
334
0.75
0.73
1.4
1.4
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
15
100
1.50
0.72
1.0
2.0
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
39
308
1.27
0.72
1.1
1.2
u/l
59.8
59.2
0.02
22
210
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
13
84
1.55
0.71
1.2
1.8
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
23
310
0.74
0.71
1.4
1.6
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
19
134
1.42
0.71
2.3
2.4
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
21
287
0.73
0.71
1.6
1.5
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
9
57
1.58
0.71
1.1
1.1
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
116
1019
1.14
0.71
3.1
3.1
g/l
0.2
0.3
1.82
39
403
(3032773) Endomysium IgG Ab [Titer] in Serum
27
203
1.33
0.70
1.2
1.1
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
15
101
1.49
0.70
2.3
1.9
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
20
143
1.40
0.70
1.1
1.0
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
20
143
1.40
0.70
3.1
2.4
%
106.8
96.7
0.82
20
135
(40758558) Short blood count panel - Blood
776
7432
1.06
0.69
6.4
6.8
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
9
145
0.62
0.69
13.8
11.4
mmol/l
0.6
0.6
—
9
134
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
42
337
1.25
0.69
1.1
1.1
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
68
574
1.19
0.69
1.5
1.6
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
5
27
1.85
0.68
1.2
1.2
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
7
42
1.67
0.68
1.4
1.6
—
—
—
0
0
(3036603) Volume of Urine
25
187
1.34
0.68
1.3
1.4
ml
2123.2
1952.5
—
5
35
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
41
329
1.25
0.67
1.5
1.8
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
84
724
1.16
0.67
2.7
2.1
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
123
1090
1.13
0.67
2.1
2.4
g/l
9.9
10.4
0.79
102
927
(3035320) C reactive protein [Mass/volume] in Body fluid
27
205
1.32
0.67
2.8
2.4
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
58
484
1.20
0.67
1.7
1.6
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
108
949
1.14
0.67
3.3
3.5
mg/l
40.1
119.1
0.72
85
768
(3023520) Reticulocytes [#/volume] in Blood
268
2477
1.09
0.67
2.9
2.6
e9/l
71.8
70.8
0.15
208
1868
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
7
43
1.63
0.66
8.9
12.1
mmol/l
4.4
6.0
—
7
43
(3009466) Valproate [Moles/volume] in Serum or Plasma
33
418
0.79
0.66
4.5
5.3
umol/l
360.0
359.4
0.01
28
363
(3000034) Microalbumin [Mass/volume] in Urine
22
294
0.75
0.66
2.5
3.0
mg/l
8.6
38.4
2.78
17
218
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
240
2210
1.09
0.65
1.3
1.3
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
10
62
1.61
0.65
7.2
8.1
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
39
313
1.25
0.65
1.2
1.2
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
85
736
1.16
0.65
2.8
2.3
ug/min
90.8
100.6
0.08
43
454
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
19
137
1.39
0.64
4.0
4.1
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
32
251
1.28
0.64
1.1
1.6
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
5
29
1.73
0.64
1.0
1.2
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
27
207
1.31
0.63
1.4
1.4
u/ml
19.2
18.7
—
5
38
(3027008) Opiates [Presence] in Urine
84
729
1.16
0.63
2.7
2.1
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
19
138
1.38
0.62
1.0
1.2
—
4.3
—
0
9
(3004616) Nuclear Ab [Presence] in Serum
42
342
1.23
0.62
1.2
1.2
—
—
—
0
0
(44813793)
12
176
0.68
0.61
1.2
1.0
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
63
535
1.18
0.61
1.4
1.4
mmol/l
64.2
61.4
0.21
49
432
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
70
600
1.17
0.61
3.5
3.8
%
55.8
57.5
0.48
70
600
(44806071)
5
30
1.67
0.61
1.2
1.1
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
16
222
0.72
0.61
1.2
1.2
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
38
307
1.24
0.61
1.0
1.1
u/ml
4.7
2.9
0.28
15
111
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
9
139
0.65
0.60
1.7
1.4
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
84
732
1.15
0.60
2.7
2.1
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
9
141
0.64
0.60
1.0
1.0
—
—
—
0
0
(3045462) Protein/Creatinine [Ratio] in Urine
0
21
0.00
0.60
0.0
4.4
—
15.9
—
0
21
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
12
80
1.50
0.59
1.0
1.1
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
25
322
0.77
0.59
1.4
1.4
e6/l
29840.8
81810.4
1.15
17
202
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
11
72
1.53
0.59
1.0
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
11
72
1.53
0.59
1.0
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
11
72
1.53
0.59
1.0
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
11
72
1.53
0.59
1.0
1.1
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
16
114
1.41
0.58
1.1
1.2
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
130
1169
1.12
0.58
2.1
2.4
g/l
3.8
3.8
0.05
95
842
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
8
53
1.51
0.58
1.4
1.1
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
7
114
0.61
0.58
1.7
1.6
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
132
1189
1.11
0.57
2.2
2.0
ug/l
2.4
2.3
0.02
106
1063
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
130
1170
1.12
0.57
2.1
2.4
g/l
7.4
7.3
0.16
97
885
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
130
1170
1.12
0.57
2.1
2.4
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
27
342
0.79
0.57
1.4
1.5
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
12
81
1.48
0.57
2.1
2.8
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
12
81
1.48
0.57
2.1
2.8
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
29
229
1.27
0.56
2.6
1.9
umol/l
24.7
5.5
0.74
19
166
(3038026) Centromere Ab [Units/volume] in Serum
29
229
1.27
0.56
1.1
1.1
—
57.3
—
0
9
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
6
36
1.67
0.56
1.0
1.1
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
11
73
1.51
0.56
1.0
1.2
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
5
89
0.56
0.56
1.0
2.3
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
6
37
1.62
0.55
2.0
2.2
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
13
90
1.45
0.55
1.2
1.8
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
21
159
1.32
0.55
1.6
2.1
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
81
710
1.14
0.55
1.3
1.1
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
98
871
1.13
0.54
1.8
1.7
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
23
177
1.30
0.54
2.3
2.8
%
44.4
40.2
—
7
58
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
6
38
1.58
0.54
1.0
1.3
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
6
38
1.58
0.54
1.0
1.3
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
6
38
1.58
0.54
1.0
1.3
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
16
116
1.38
0.54
6.8
6.2
mg/l
84.3
61.4
—
8
82
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
12
82
1.47
0.54
1.1
1.2
%
98.3
103.8
0.23
12
76
(3045142) Bone marrow Pathology biopsy report
28
350
0.80
0.54
1.3
1.3
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
42
349
1.21
0.53
3.4
2.5
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
122
1100
1.11
0.53
2.2
2.5
g/l
3.1
3.1
0.09
95
864
(3022806) Fractional oxyhemoglobin in Capillary blood
47
395
1.19
0.53
1.6
1.9
%
89.8
89.3
0.29
47
389
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
39
470
0.83
0.53
1.2
1.1
iu/ml
49.2
1332.9
—
10
100
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
66
572
1.16
0.53
3.6
5.7
iu/ml
428.1
580.3
0.23
12
86
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
28
223
1.26
0.52
1.1
1.1
—
61.0
—
0
8
(3025018) Bordetella pertussis Ab [Titer] in Serum
20
152
1.32
0.52
1.4
1.2
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
351
3318
1.06
0.51
3.0
2.8
umol/l
7.7
8.2
0.16
299
2903
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
6
40
1.50
0.51
1.0
1.1
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
35
287
1.22
0.51
1.2
1.4
e6/l
388063.5
85512.7
0.71
26
201
(3025577) Chromium [Mass/volume] in Blood
23
179
1.29
0.51
2.0
2.0
ug/l
2.2
2.3
0.07
18
151
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
11
157
0.70
0.51
1.0
1.6
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
11
157
0.70
0.51
1.0
1.6
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
32
391
0.82
0.51
1.1
1.0
u/ml
6.1
4.3
0.32
14
191
(3023199) Leukocytes [#/volume] in Pleural fluid
29
358
0.81
0.51
1.4
1.4
e6/l
3666.0
1716.8
0.59
22
269
(3039443) Prostate specific Ag panel - Serum or Plasma
67
584
1.15
0.50
1.9
1.6
—
—
—
0
0
(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]
9
65
1.39
0.50
2.3
7.2
%
58.9
71.1
—
9
54
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
103
924
1.12
0.50
3.4
3.5
ratio
1.4
2.1
0.46
11
72
(3034426) Prothrombin time (PT)
13
92
1.41
0.50
1.3
1.3
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
90
801
1.13
0.50
2.2
2.3
%
186.9
192.3
0.20
84
763
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
6
41
1.46
0.50
1.0
1.2
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
12
84
1.43
0.49
1.7
1.7
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
31
378
0.82
0.49
1.1
1.1
u/ml
1.0
1.2
0.15
14
153
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
20
154
1.30
0.48
1.0
1.1
u/l
23.5
26.1
0.12
15
115
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
7
46
1.52
0.48
1.0
1.6
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
26
208
1.25
0.48
1.0
1.2
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
105
948
1.11
0.47
3.4
3.5
mg/l
29.3
67.5
1.78
82
767
(3041806) Other cells [#/volume] in Blood by Manual count
7
48
1.46
0.46
2.0
1.5
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
15
111
1.35
0.46
1.1
1.0
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
172
1592
1.08
0.46
7.8
10.5
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
33
397
0.83
0.46
1.4
1.5
g/l
35.8
32.5
0.86
33
360
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
83
740
1.12
0.46
1.6
1.3
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
8
117
0.68
0.45
1.6
1.9
ug/l
22.1
19.8
—
8
105
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
5
83
0.60
0.45
1.4
1.5
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
51
440
1.16
0.45
1.4
1.3
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
28
228
1.23
0.45
1.1
1.4
promille
1.8
1.2
1.21
21
177
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
26
210
1.24
0.45
1.0
1.2
—
—
—
0
0
(4198724)
12
86
1.40
0.44
1.4
1.8
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
301
2852
1.06
0.43
2.2
2.2
g/l
0.2
0.2
0.43
276
2664
(3043410) Blood group antigens tested for on Red Blood Cells
6
91
0.66
0.42
1.8
1.9
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
27
221
1.22
0.42
1.2
1.2
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
26
212
1.23
0.42
2.8
1.5
ug/l
4.3
4.4
0.02
21
179
(3045716) Anion gap in Serum or Plasma
19
149
1.28
0.41
2.6
2.5
mmol/l
9.3
9.5
0.07
14
117
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
93
842
1.11
0.41
1.2
1.1
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
5
33
1.52
0.41
2.6
1.3
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
34
402
0.84
0.41
1.4
1.4
—
—
—
0
0
(3018840) Calcitonin [Moles/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
2.1
—
1.9
—
0
5
(3027974) Hepatitis B virus e Ag [Presence] in Serum
0
16
0.00
0.41
0.0
1.8
—
—
—
0
0
(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.0
—
1.7
—
0
11
(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay
0
16
0.00
0.41
0.0
1.3
—
4334.6
—
0
10
(3004593) Baker's yeast IgA Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.3
—
32.3
—
0
7
(3008092) Baker's yeast IgG Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.3
—
23.0
—
0
5
(3036525) Urea [Moles/time] in 24 hour Urine
0
17
0.00
0.40
0.0
3.8
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood
0
17
0.00
0.40
0.0
1.4
—
22.7
—
0
6
(3013762) Body weight Measured
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
15
114
1.32
0.40
1.1
1.3
—
0.3
—
0
10
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
34
401
0.85
0.40
1.4
1.4
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
78
701
1.12
0.40
1.7
1.7
e6/l
15314.8
13570.8
0.11
53
515
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
54
474
1.14
0.40
1.2
1.2
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
36
306
1.18
0.39
1.1
1.1
%
96.0
95.8
0.02
36
289
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
30
357
0.84
0.39
1.0
1.1
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
34
400
0.85
0.39
1.4
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
34
400
0.85
0.39
1.4
1.4
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
47
409
1.15
0.39
1.2
1.4
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
63
560
1.13
0.39
3.2
2.1
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
20
248
0.81
0.39
3.1
2.2
ml
674.9
636.2
0.17
15
162
(3052851) Hemolysis interference index of Serum or Plasma
95
865
1.10
0.39
2.6
3.6
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
164
1530
1.08
0.39
6.7
9.5
mmol/l
24.5
24.3
0.24
150
1437
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
46
400
1.15
0.39
1.1
1.1
g/l
1.5
1.5
0.22
40
358
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
9
66
1.36
0.38
1.1
1.2
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
196
1842
1.07
0.38
1.7
1.6
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
41
473
0.87
0.38
1.7
1.5
—
—
—
0
0
(40768441) Liver Pathology biopsy report
26
215
1.21
0.38
1.7
1.4
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
18
225
0.80
0.38
1.8
1.5
g/l
0.9
1.0
0.89
18
225
(3020491) Glucose [Moles/volume] in Blood
25
206
1.22
0.38
1.4
2.0
mmol/l
7.2
6.9
0.08
15
132
(40768800) Prostate Pathology biopsy report
68
609
1.12
0.37
1.1
1.2
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
143
1330
1.08
0.37
2.0
1.9
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
38
440
0.86
0.37
1.3
1.5
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
8
113
0.71
0.37
1.1
1.1
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
83
753
1.10
0.37
1.3
1.2
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
15
116
1.29
0.37
1.5
1.6
mmol/l
6.9
8.1
—
8
73
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
98
897
1.10
0.37
1.7
1.8
—
—
—
0
0
(1616796) Gas panel - Central venous blood
75
677
1.11
0.36
2.9
4.0
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
96
879
1.09
0.36
2.3
2.4
g/l
0.0
0.0
0.21
88
809
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
6
42
1.43
0.35
1.0
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
25
208
1.20
0.35
1.0
1.2
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
100
919
1.09
0.35
2.2
2.3
g/l
39.3
37.7
2.53
86
789
(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma
6
43
1.40
0.35
1.3
1.3
nmol/l
3.6
760005.2
—
6
35
(3004809) Band form neutrophils/100 leukocytes in Blood
54
480
1.13
0.34
4.1
3.6
%
1.5
1.4
0.07
44
374
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
19
233
0.81
0.34
1.4
1.6
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
25
209
1.20
0.34
1.0
1.2
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
18
145
1.24
0.33
1.2
1.2
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
31
265
1.17
0.33
7.3
5.2
u/ml
370.6
64.5
0.43
12
73
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
74
813
0.91
0.33
1.4
1.5
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
25
210
1.19
0.32
1.0
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
25
210
1.19
0.32
1.0
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
93
857
1.09
0.32
1.2
1.2
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
24
284
0.84
0.31
1.3
1.3
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
139
1482
0.94
0.31
4.3
3.4
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
7
52
1.35
0.31
1.6
1.2
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
24
202
1.19
0.31
1.1
1.5
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
92
849
1.09
0.31
1.2
1.1
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
21
251
0.84
0.31
1.2
1.6
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
73
667
1.10
0.30
2.9
2.2
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
16
129
1.24
0.30
2.7
3.9
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
50
448
1.12
0.29
2.1
1.7
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
89
823
1.08
0.29
2.3
2.4
g/l
3.3
3.6
1.13
84
777
(3020779) Urea [Moles/volume] in Serum or Plasma
279
2677
1.05
0.29
7.2
7.6
mmol/l
9.9
10.0
0.03
258
2558
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
31
269
1.15
0.29
1.0
1.0
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
35
398
0.88
0.29
1.1
1.1
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
17
206
0.82
0.29
1.4
1.5
pmol/l
19.9
189.0
—
6
70
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
21
176
1.19
0.28
1.1
1.6
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
21
176
1.19
0.28
1.1
1.6
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
14
112
1.25
0.28
1.4
2.8
umol/l
306.0
151.1
—
8
66
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
14
112
1.25
0.28
1.1
1.1
miu/ml
1540.9
1561.6
0.03
14
112
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
36
317
1.14
0.28
1.9
1.7
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
12
94
1.28
0.28
1.0
1.1
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
11
85
1.30
0.28
1.3
1.5
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
92
854
1.08
0.28
1.4
1.3
—
—
—
0
0
(4281824)
27
312
0.86
0.28
1.1
1.2
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
8
63
1.27
0.27
1.4
2.2
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
10
77
1.30
0.26
1.0
1.1
—
—
—
0
0
(4211845)
17
141
1.21
0.26
2.6
3.8
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
9
72
1.25
0.25
1.0
1.1
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
77
714
1.08
0.25
3.4
3.6
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
318
3289
0.96
0.25
1.6
1.8
%
1.4
1.5
3.71
273
2889
(4015189)
9
75
1.20
0.25
2.6
2.3
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
34
302
1.13
0.24
1.2
1.2
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
107
1006
1.07
0.24
2.6
2.5
g/l
0.6
1.1
1.34
93
870
(3003694) ABO and Rh group [Type] in Blood
770
7850
0.98
0.24
1.4
1.4
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
21
180
1.17
0.23
9.9
6.8
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
38
341
1.12
0.23
1.3
1.3
mmol/l
7.0
7.4
0.37
29
256
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
88
823
1.07
0.23
2.3
2.4
g/l
0.0
0.0
0.00
82
757
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
40
443
0.90
0.23
1.1
1.1
u/ml
4.2
1.7
0.28
15
175
(3025130) Human papilloma virus identified in Specimen
37
332
1.12
0.23
1.5
1.8
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
130
1370
0.95
0.23
3.9
4.0
mmol/l
24.0
24.2
0.23
116
1231
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
12
97
1.24
0.23
2.3
1.3
umol/l
4.5
4.1
0.21
12
92
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
70
753
0.93
0.22
1.5
1.6
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
468
4564
1.03
0.22
3.2
2.9
e6/l
2.3
2.5
0.13
248
2480
(21494890) Protein electrophoresis panel - 24 hour Urine
36
323
1.12
0.22
2.3
2.0
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
11
88
1.25
0.22
1.2
1.1
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
11
88
1.25
0.22
1.2
1.1
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
10
79
1.27
0.22
1.0
1.1
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
15
178
0.84
0.22
1.5
1.1
—
—
—
0
0
(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid
0
11
0.00
0.21
0.0
6.1
—
424.6
—
0
11
(3011325) HIV 1+2 Ab [Presence] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3022725) Serotonin [Moles/volume] in Serum
0
11
0.00
0.21
0.0
1.8
—
752.6
—
0
11
(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
4.4
—
—
—
0
0
(3027401) Testosterone Free/Testosterone.total in Serum or Plasma
0
10
0.00
0.21
0.0
1.6
—
1.4
—
0
10
(3013862) HLA-DP [Type]
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3016031) Almond IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.0
—
0.1
—
0
5
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
12
0.00
0.21
0.0
1.2
—
2.4
—
0
12
(40760410) HLA-B [Type] by High resolution
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
23
201
1.15
0.21
1.5
2.5
e6/l
631.4
715.7
—
10
84
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
60
556
1.08
0.21
1.4
1.4
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
5
43
1.16
0.21
2.6
1.1
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
5
43
1.16
0.21
5.2
4.3
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
5
43
1.16
0.21
1.2
1.6
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
8
105
0.76
0.21
1.0
1.1
—
—
—
0
0
(44806118)
32
356
0.90
0.21
1.3
1.4
—
—
—
0
0
(44790049)
32
356
0.90
0.21
1.3
1.4
—
—
—
0
0
(44790047)
32
356
0.90
0.21
1.3
1.4
—
—
—
0
0
(44790048)
32
356
0.90
0.21
1.3
1.4
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
47
512
0.92
0.21
1.3
1.2
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.6
—
12.6
—
0
13
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
39
354
1.10
0.20
1.5
1.8
ug/l
22.3
26.4
0.29
39
349
(3000093) Morphology [Interpretation] in Blood Narrative
23
261
0.88
0.20
1.1
1.1
—
—
—
0
0
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
0
14
0.00
0.20
0.0
1.9
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
11
90
1.22
0.19
1.1
1.1
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
13
154
0.84
0.19
1.6
2.1
ug/min
115.6
190.7
—
5
33
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
10
81
1.24
0.18
1.0
1.3
%
83.8
88.3
—
5
45
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
7
59
1.19
0.18
5.7
2.5
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
82
775
1.06
0.18
1.2
1.2
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
64
682
0.94
0.17
2.6
2.2
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
7
61
1.15
0.17
1.1
1.2
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
7
62
1.13
0.17
1.4
2.4
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
21
186
1.13
0.17
1.3
1.1
mmol/l
31.3
34.8
0.30
15
165
(21494434) Karyotype in Bone marrow
24
267
0.90
0.16
1.1
1.2
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
51
476
1.07
0.16
1.7
1.4
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
46
428
1.08
0.16
1.2
1.4
—
—
—
0
0
(3024263) Appearance of Synovial fluid
19
168
1.13
0.15
2.2
1.7
—
—
—
0
0
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
10
83
1.21
0.15
1.0
1.1
%
85.2
89.7
—
5
46
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
10
119
0.84
0.15
1.0
1.1
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
9
78
1.15
0.15
3.6
1.6
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
9
80
1.13
0.15
1.2
1.1
—
—
—
0
0
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
25
226
1.11
0.15
1.0
1.0
ng/l
783.7
723.2
0.20
14
145
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
25
226
1.11
0.15
1.0
1.0
ng/l
253.3
322.3
0.88
15
148
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
28
255
1.10
0.15
1.7
1.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
9
81
1.11
0.15
1.2
1.0
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
61
646
0.94
0.15
1.1
1.5
—
—
—
0
0
(44806420)
9
83
1.08
0.14
2.0
2.5
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
7
88
0.80
0.14
10.0
5.3
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
139
1342
1.04
0.14
1.7
1.8
g/l
1.4
1.5
0.73
120
1153
(3006442) Creatine [Moles/volume] in Serum or Plasma
23
208
1.11
0.14
1.6
1.5
—
72.8
—
0
19
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
10
84
1.19
0.14
1.1
3.1
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
63
597
1.06
0.14
3.0
3.2
nmol/l
0.8
0.8
0.05
53
456
(21494755) Public health laboratory ask at order entry panel
235
2409
0.97
0.13
1.4
1.4
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
230
2358
0.97
0.13
1.8
1.8
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
25
228
1.10
0.13
1.0
1.0
ng/l
41.7
46.2
0.17
15
146
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
52
491
1.06
0.13
1.5
1.4
u/ml
88.8
119.9
1.45
15
94
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
24
219
1.10
0.12
1.0
1.2
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
10
85
1.18
0.12
1.1
1.1
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
50
473
1.06
0.12
1.2
1.4
—
—
—
0
0
(4035726)
265
2705
0.98
0.12
1.3
1.4
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
10
116
0.86
0.12
3.4
2.3
—
—
—
0
0
(3000492) Spirometry study
279
2737
1.02
0.11
1.3
1.5
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
14
124
1.13
0.11
1.1
1.0
u/ml
0.6
0.5
—
6
34
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
42
396
1.06
0.11
1.1
1.1
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
96
994
0.96
0.11
1.7
1.7
mg/l
3.3
4.1
0.48
73
704
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
10
86
1.16
0.11
1.5
1.4
ug/l
8.3
8.9
—
10
86
(3027923) C peptide [Moles/volume] in Serum or Plasma
18
163
1.10
0.10
1.5
1.3
nmol/l
1.1
1.2
0.07
13
128
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
15
167
0.90
0.10
1.1
1.4
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
5
45
1.11
0.09
1.2
1.1
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
56
536
1.05
0.09
1.2
1.4
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
28
299
0.94
0.09
1.8
2.0
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
20
184
1.09
0.09
1.4
1.8
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
21
227
0.92
0.09
1.2
1.2
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
30
282
1.06
0.09
1.0
1.1
u/ml
10.1
3.4
—
10
106
(3036048) Francisella tularensis Ab [Titer] in Serum
7
64
1.09
0.08
1.0
1.1
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
8
74
1.08
0.07
1.0
1.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
37
388
0.95
0.07
1.3
1.2
—
—
—
0
0
(3008898) HLA-B27 [Presence]
90
876
1.03
0.07
1.1
1.1
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
8
77
1.04
0.07
1.0
1.9
mmol/l
0.5
1.2
—
8
71
(3037692) Legionella sp identified in Specimen by Organism specific culture
12
108
1.11
0.07
1.0
1.4
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
64
620
1.03
0.07
2.8
2.8
—
—
—
0
0
(3024471) HLA-A [Type]
8
91
0.88
0.06
1.0
1.0
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
8
92
0.87
0.06
1.1
1.2
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
8
93
0.86
0.06
1.1
1.1
—
—
—
0
0
(4024509)
30
285
1.05
0.06
1.5
1.7
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
49
508
0.96
0.06
1.4
1.3
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
71
729
0.97
0.06
5.8
4.3
—
—
—
0
0
(3011648) Oxygen content in Venous blood
25
237
1.06
0.05
2.8
1.9
%
12.5
11.3
0.77
25
237
(3020874) Milk IgE Ab [Units/volume] in Serum
14
129
1.09
0.05
1.1
1.0
u/ml
0.4
1.0
—
5
46
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
16
149
1.07
0.05
1.3
1.1
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
30
287
1.05
0.05
1.1
1.2
—
—
—
0
0
(3017704) Immunofixation for Urine
16
171
0.94
0.05
1.8
1.6
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
12
130
0.92
0.04
3.6
2.6
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
88
897
0.98
0.04
1.4
1.4
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
50
514
0.97
0.04
1.1
1.2
u/ml
253.3
285.1
0.41
34
313
(3051611) Lipemic interference index of Serum or Plasma
29
302
0.96
0.04
1.9
3.7
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
109
1107
0.98
0.04
3.7
3.4
u/ml
741.1
4534.7
0.82
95
944
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
54
553
0.98
0.03
1.5
1.7
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
191
1929
0.99
0.03
1.3
1.4
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
47
482
0.97
0.03
4.0
2.9
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
80
788
1.02
0.03
1.4
1.3
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
72
709
1.02
0.02
1.5
1.8
iu/l
2.5
4.6
5.08
21
244
(3004451) EKG impression Narrative
15
158
0.95
0.02
1.3
1.3
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
37
361
1.03
0.02
1.1
1.1
u/ml
1.8
2.1
—
9
85
(3023419) Bacteria identified in Sputum by Culture
40
391
1.02
0.02
2.0
2.5
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
153
1542
0.99
0.02
1.4
1.5
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
29
282
1.03
0.02
1.1
1.3
nmol/l
1.4
1.4
0.11
24
257
(3028707) Methadone [Presence] in Urine by Screen method
33
322
1.03
0.01
4.9
2.8
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
65
641
1.01
0.01
2.8
2.8
umol/l
32.5
36.8
0.78
55
541
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
11
117
0.94
0.01
1.0
1.3
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
16
153
1.05
0.01
2.2
1.6
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
76
752
1.01
0.01
1.4
1.6
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
14
146
0.96
0.00
2.7
3.2
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
23
236
0.97
0.00
1.0
1.1
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
30
298
1.01
0.00
2.2
2.5
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
14
141
0.99
0.00
1.0
2.4
u/ml
4582.7
1147.7
0.38
14
141
(3017569) Oxygen content in Arterial blood
15
151
0.99
0.00
1.8
2.2
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
26
259
1.00
0.00
1.5
1.5
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
36
361
1.00
0.00
1.5
1.5
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
73
731
1.00
0.00
1.4
1.6
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
48
476
1.01
0.00
1.4
1.4
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
18
176
1.02
0.00
1.1
1.2
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
17
173
0.98
0.00
1.5
3.9
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
6
61
0.98
0.00
1.3
1.6
—
—
—
0
0
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
0
9
0.00
0.00
0.0
9.0
—
—
—
0
0
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014591) Smooth Alder IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.6
—
1.9
—
0
9
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
5
56
0.89
0.00
7.2
3.0
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
6
66
0.91
0.00
1.2
1.3
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
7
72
0.97
0.00
1.4
1.7
—
—
—
0
0
(3018291) Platelet Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3012989) Citrate [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.4
—
1.9
—
0
7
(36303858) Crystals [Presence] in Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count
0
5
0.00
0.00
0.0
5.2
—
—
—
0
0
(3007463) Buprenorphine [Presence] in Urine
0
7
0.00
0.00
0.0
2.1
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
6
62
0.97
0.00
1.0
1.3
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024932) HLA-DR beta [Type]
8
89
0.90
0.00
1.0
1.1
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
8
87
0.92
0.00
1.0
1.3
—
—
—
0
0
(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count
0
5
0.00
0.00
0.0
8.0
—
74.8
—
0
5
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000690) Aldosterone [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
25.8
—
0
5
(3033086) Enterovirus NOS Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
9
94
0.96
0.00
1.2
1.4
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023383) Lactate [Moles/volume] in Pleural fluid
9
93
0.97
0.00
1.3
1.4
mmol/l
3.1
3.2
—
9
83
(3041918) Cholesterol [Moles/volume] in Pleural fluid
5
58
0.86
0.00
1.4
1.2
mmol/l
1.5
1.7
—
5
40
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
7
69
1.01
0.00
1.3
1.2
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
6
65
0.92
0.00
1.5
1.3
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
55
550
1.00
0.00
1.1
1.2
—
—
—
0
0
(3048879) Bone marrow aspiration report
8
85
0.94
0.00
1.6
1.9
—
—
—
0
0
(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
6
67
0.90
0.00
1.5
1.4
%
5.3
24.3
—
6
54
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
6
68
0.88
0.00
1.3
1.3
—
—
—
0
0
(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3046682) IgA [Presence] in Skin by Immunofluorescence
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3046904) Somatotropin [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
1.6
—
0
5
(3034614) HLA Ag [Interpretation]
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3006567) Chloride [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
1.3
—
0
6
(3017937) Magnesium [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint H8_VESTIBNEUR and mortality.

Females

Parameter HR [95% CI] p-value
H8_VESTIBNEUR 0.785 [0.71, 0.87] < 0.001
Birth year 0.997 [0.99, 1.01] 0.546

During the follow-up period (1.1.1998 — 31.12.2019), 927 out of 9696 females with H8_VESTIBNEUR died.

Males

Parameter HR [95% CI] p-value
H8_VESTIBNEUR 0.686 [0.61, 0.77] < 0.001
Birth year 0.988 [0.98, 1.0] 0.009

During the follow-up period (1.1.1998 — 31.12.2019), 874 out of 8342 males with H8_VESTIBNEUR died.

Mortality risk

Mortality risk for people of age

years, who have H8_VESTIBNEUR.

N-year risk Females Males
1 0.077% 0.117%
5 0.463% 0.769%
10 1.285% 1.988%
15 2.53% 3.927%
20 4.332% 6.882%

Relationships between endpoints

↥

Index endpoint: H8_VESTIBNEUR – Vestibular neuronitis

GWS hits: 2

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data